Safety and Performance of SoftOx Wound Irrigation Solution (SWIS) in Acute Wounds

Acute Wounds Clinical Trial

— SWIS-01  

Official title:

Pilot Study to Document Safety and Performance of SoftOx Wound Irrigation Solution in Patients With Split Skin Wounds (Donor Site) Undergoing Skin Transplantation. A Human Model for Acute Trauma Wounds

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03742284
• Other study ID #: CIV-18-08-025365
• Status: Recruiting
• Phase: N/A
• Start date: November 12, 2018
• Est. completion date: June 15, 2019

Study information

• Verified date: March 2019
• Source: SoftOx Solutions AS
• Contact: Ewa A Burian, MD
• Phone: +45 53 60 91 59
• Email: ewa.anna.burian[@]regionh.dk
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This pilot study evaluates safety and performance of the Medical device, SoftOx Wound Irrigation Solution (SWIS), in a model for acute wounds.

Description:

This is a pilot study with an open-label, exploratory study design with the aim to document preliminary safety and performance of the SoftOx Wound Irrigation Solution while used as intended by the manufacturer, i.e. as an irrigation solution for mechanical rinsing of breached or compromised skin as a result from acute wounds. This first-in-man study will give valuable information on the feasibility of the treatment with the SoftOx Wound Irrigation Solution to prepare for continuous studies in clinically significant settings prior CE marking. The investigation population will consist of 12 subjects undergoing split skin graft transplantation for treating chronic leg ulcers and that are fulfilling the eligibility criteria for the clinical investigation. The SoftOx Wound Irrigation Solution will be applied on the donor site of the split skin graft which is a representative model of acute wounds in a controlled setting. All subjects will be followed up for 21 days. The duration of the investigation is estimated to 4 months.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 12
• Est. completion date: June 15, 2019
• Est. primary completion date: May 31, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Age 18 and older

2. Non-healing, leg ulcers, that are scheduled for an operation with excision of the chronic leg ulcer and split skin transplantation

3. Been informed of the nature, the scope and the relevance of the clinical investigation

4. Voluntarily agreed to participation and has duly signed the Informed Consent Form

Exclusion Criteria:

1. Participating in any other clinical investigation

2. On systemic immunomodulating drugs

3. On systemic steroid treatment up to four (4) weeks prior to study inclusion

4. On strong pain medication (e.g. opioids)

5. Severe neuropathy (or dysesthesia on the donor site)

6. Pregnancy

7. Dementia

8. Allergy to polyurethane foam, hypochlorous acid, acetic acid or any other remedies/material used in the clinical investigation

9. Not able to read or understand Danish

10. Any other conditions that as judged by the investigator may make follow-up or investigation inappropriate

11. That according to the Declaration of Helsinki is deemed unsuitable for study enrolment

Related Conditions & MeSH terms

• Acute Wounds
• Wounds and Injuries

Intervention

Device:
• SoftOx Wound Irrigation Solution
The SoftOx Wound Irrigation Solution is a Medical device that contains a combination of hypochlorous acid and acetic acid in purified water. SWIS is primary intended for mechanical irrigation of acute wounds whereas hypochlorous acid acts as a ancillary medicinal (drug) substance with potential antimicrobial effects. Acute wounds will be rinsed according to protocol and safety (AEs/ADEs/SAEs/SADEs) is the primary objective.

Locations

Country	Name	City	State
Denmark	Bispebjerg University Hospital	Copenhagen

Sponsors (1)

Lead Sponsor	Collaborator
SoftOx Solutions AS

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	- The incidence and severity of any adverse events associated with the SoftOx Wound Irrigation Solution	Incidence and severity of any adverse events related to the SoftOx Wound Irrigation Solution will be summarized in terms of frequencies (n), percentages (%) and the mode.	Evaluation over 21 days